PRCT PROCEPT® BioRobotics Corporation

NASDAQ
$17.20

PROCEPT® BioRobotics Corporation (PRCT) is expected to report earnings on November 3, 2026, after the market close. The consensus earnings estimate is a loss of $0.39 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -1.5% since its last earnings release on August 4, 2026.

PROCEPT® BioRobotics Missed Consensus Estimates, Reaffirms
Tuesday, August 4, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 3
Tuesday · 4:05 PM ET
Earnings Whisper
-
vs ($0.39)
Rev est $100.07M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $20.34

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About PROCEPT® BioRobotics Corporation

PROCEPT is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology.

Sector

Healthcare

Industry

Medical Instruments/Supply

Held By 3 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.